Month: November 2019

Thanksgiving is just days away!
We’ll soon be stuffing ourselves with turkey and all the side dishes that round out our meal.
Then we’ll nap, watch some football and likely do some holiday shopping.
We also have a shortened trading week in front us. But by no means does that mean there’s less market-moving news to digest.
Last week, our High Five focused on U.S. multistate operators (MSOs).
And, boy, did they deliver!
And adding to the bright earnings from Green Thumb Industries (OTC: GTBIF), Trulieve Cannabis (OTC: TCNNF) and others was a major catalyst out of Capitol Hill.
This triggered a massive rally…
Pass MORE
Even though pot …read more […]

Last week, Alex discussed a recent debate of socialism versus capitalism that he attended.
How is it possible that socialism won? Our free market system provides endless opportunities where socialism has continually failed.

To be a successful investor, you have to understand a few basics about how the economy works.
You also need to know what doesn’t work. Indeed, what has never worked.
One of those things is socialism, currently favored by millennials and Gen Xers.
Two weeks ago, my mind was blown when the audience at an Intelligence Squared debate in New York City fell for the bogus arguments, misstatements of fact and outright …read more […]

Guru’s largest buys of the 3rd quarter Continue reading… …read more […]

The tech giant is remarkably effective at skirting the Trump tariffs that hamstring other companies. …read more […]

The FCC moves ahead with a proposal on removing existing Huawei and ZTE equipment from U.S. wireless network, which could be costly to rural carriers. …read more […]

Can you feel the ground moving beneath your feet? Shares of Sorrento Therapeutics (SRNE) skyrocket 70% today after the small drug maker were made an offer they could, apparently, refuse. The biotech announced it received an unsolicited proposal by two biopharmaceutical companies to acquire all the company’s issued and outstanding shares, in cash, for a price between $3 and $5 per share. After consulting with the company’s advisors, the board rejected the offer on the basis the deal significantly undervalued the biotech and would be against stockholders’ interests. Sorrento believes its immuno-oncology products have short- and long-term value and has …read more […]

The number of North American shale bankruptcies have soared since September, and the investors that thought that the bust was over are now forced to re-think their strategy …read more […]

Can Uber survive after London regulators stripped the license of the ride-sharing company in London? Yahoo Finance’s Julie Hyman, Adam Shapiro, Oscar Williams-Grut, Brian Sozzi and Andy Serwer discuss. …read more […]

Canada’s Nutrien Ltd, the world’s biggest fertilizer company by capacity, said on Monday it would temporarily shut its largest potash mine due to a railway strike. The strike by some 3,200 unionized employees at Canadian National Railway Co entered its seventh day, leaving more than 30 vessels waiting on Canada’s West Coast. Nutrien said in a statement that it would shut its Rocanville, Saskatchewan mine for two weeks starting Dec. 2. …read more […]

Wall Street is seeing a spate of mergers but what does consolidation mean for consumers and how can investors benefit. Yahoo Finance’s Julie Hyman, Adam Shapiro, Brian Sozzi, Andy Serwer and Brian Chueng break it down. …read more […]

Last night was the American Music Awards, and the big winner was Taylor Swift. The singer took home five trophies and was named the AMA’s Artist of the Decade. Swift performed a medley of some of her biggest hits, including songs at the heart of her rights dispute with her former label. Some of the night’s other winners included Billie Eilish and Lil Nas X. Jem Aswad, senior music editor at Variety, is joins Yahoo Finance to break down the night. …read more […]

Some thoughts on one of the Oracle of Omaha’s biggest mistakes Continue reading… …read more […]